1.
Khasabova IA, Gable J, Johns M, Khasabov SG, Kalyuzhny AE, Golovko MY, Golovko SA, Kiven S, Gupta K, Seybold VS, Simone DA. Inhibition of DAGLĪ² as a therapeutic target for pain in sickle cell disease. Haematologica 2022;108(3):859-869; https://doi.org/10.3324/haematol.2021.280460.